What is NDC 46708-405?

46708-405 is the product NDC for Silodosin, Silodosin 4 mg/1 capsule, listed with the FDA by Alembic Pharmaceuticals Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.

Alembic Pharmaceuticals Limited, NDC labeler code 46708. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Silodosin?

28 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Silodosin NDC 46708-405 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)46708-405Labeler and product segments. Claims need a package NDC.

Product NDC at billing width46708-0405Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
46708-405-30	4670804053046708040530	30 CAPSULE in 1 BOTTLE (46708-405-30)Marketed from Nov 25, 2019
46708-405-90	4670804059046708040590	90 CAPSULE in 1 BOTTLE (46708-405-90)Marketed from Nov 25, 2019
46708-405-91	4670804059146708040591	1000 CAPSULE in 1 BOTTLE (46708-405-91)Marketed from Nov 25, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Silodosin
Generic name (nonproprietary): silodosin
Active ingredients: Silodosin — 4 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Alembic Pharmaceuticals LimitedNDC labeler code 46708
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211731
Marketing start: Nov 25, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 46708-405_74147395-217c-4a7c-8acf-92a95ca7b7d4SPL ID 74147395-217c-4a7c-8acf-92a95ca7b7d4SPL set ID 322ce16e-485f-4fd2-bb30-6b4776bc9e85RxCUI 809477, 826612UNII CUZ39LUY82UPC 0346708406301
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N446708040530 followed by a unit qualifier and the quantity

Package 46708-0405-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 30, 2023.

Indications (excerpt from the label)

Silodosin capsule, a selective alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [ see Clinical Studies (14 )]. Silodosin capsule is not indicated for the treatment of hypertension. Silodosin capsule, an alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). (1) Silodosin capsule is not indicated for the treatment of hypertension.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 46708-405

What is NDC 46708-405?: 46708-405 is the product NDC for Silodosin, Silodosin 4 mg/1 capsule, listed with the FDA by Alembic Pharmaceuticals Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Silodosin.
What is the active ingredient?: Silodosin.
Who is the labeler?: Alembic Pharmaceuticals Limited, NDC labeler code 46708. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Silodosin?: 28 other product NDCs are listed under this name. See all Silodosin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Silodosin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Silodosin	Silodosin 4 mg/1	CapsuleOral	Bryant Ranch Prepack	72162-2446	72162-2446-03
Silodosin	Silodosin 8 mg/1	CapsuleOral	Bryant Ranch Prepack	72162-2447	72162-2447-0372162-2447-09
Silodosin	Silodosin 4 mg/1	CapsuleOral	Creekwood Pharmaceuticals LLC	82619-113	82619-0113-01
Silodosin	Silodosin 8 mg/1	CapsuleOral	Creekwood Pharmaceuticals LLC	82619-114	82619-0114-0182619-0114-02
Silodosin	Silodosin 4 mg/1	CapsuleOral	AvKARE	42291-777	42291-0777-30
Silodosin	Silodosin 8 mg/1	CapsuleOral	AvKARE	42291-778	42291-0778-90
Silodosin	Silodosin 4 mg/1	CapsuleOral	Camber Pharmaceuticals, Inc.	31722-635	31722-0635-3031722-0635-3131722-0635-90+1 more
Silodosin	Silodosin 8 mg/1	CapsuleOral	Camber Pharmaceuticals, Inc.	31722-636	31722-0636-3031722-0636-3131722-0636-90+1 more
Silodosin	Silodosin 8 mg/1	CapsuleOral	Alembic Pharmaceuticals Limited	46708-406	46708-0406-3046708-0406-9046708-0406-91
Silodosin	Silodosin 4 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-405	62332-0405-3062332-0405-9062332-0405-91

All 29 Silodosin NDCs

Other NDCs under ANDA 211731

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211731
Product	Strength	Form · route	Labeler	Product NDC
Silodosin	Silodosin 8 mg/1	CapsuleOral	Alembic Pharmaceuticals Limited	46708-406
Silodosin	Silodosin 4 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-405
Silodosin	Silodosin 8 mg/1	CapsuleOral	Alembic Pharmaceuticals Inc.	62332-406